Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

NCT06923956 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolaemia
Mixed Dyslipidaemia
Cardiovascular Diseases

Interventions

DRUG: Bempedoic Acid Film Coated Tablet
DRUG: Nilemdo® (Bempedoic Acid) Film-coated tablets

Sponsor

Humanis Saglık Anonim Sirketi